Research Article
Valuable Serum Markers in Pulmonary Alveolar Proteinosis
Table 5
Comparison of DLCO-SB and other parameters between baseline and six-month follow-up in PAP patients without inhalation of the GM-CSF treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compared with baseline, a. |